Tadalafil Daily Used Post Turp

January 25, 2025 updated by: Elsayed Abdelhalim Elsayed, Kafrelsheikh University

The Effect of Tadalafil 5 mg on Erection and Persistent Storage Lower Urinary Tract Symptoms After Transurethral Resection of Prostate: a Randmized Controlled Trial

to assess the effect of early tadalafil 5 mg once daily on persistent storage lower urinary tract symptoms (LUTS) and erectile function after transurethral resection of the prostate (TURP).

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

270

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Zagazig, Egypt, 44749
        • Elsayed Abdelhalim Elsayed

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

Sexual active male patients underwent TURP

Description

Inclusion Criteria:

  • sexual active men

Exclusion Criteria:

  • sexual inactive men
  • cardiac patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patient recive tadalafil 5mg once daily early post turp
Drug: Tadalafil 5mg
Patient recive tadalafil 5mg once daily early post turp
Patient recive placebo once daily early post turp
Drug: Placebo
Patient recive placebo once daily early post turp

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assess erectile function
Time Frame: One month
Using IIEF score
One month
Assess erectile function
Time Frame: 3 month
Usine IIEF score
3 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assess storage symptoms
Time Frame: One month
Using IPSS Score
One month
Assess storage symptoms
Time Frame: 3 month
Using IPSS score
3 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Kafrelsheikh University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2021

Primary Completion (Actual)

October 1, 2022

Study Completion (Actual)

October 1, 2022

Study Registration Dates

First Submitted

January 17, 2025

First Submitted That Met QC Criteria

January 17, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 25, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Tadalafil daily used post turp

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Erectile Dysfunction Following Urethral Surgery

Clinical Trials on Tadalafil 5mg

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe